Recall report: Local anesthetic from Teligent deemed too potent
A single lot of a topical local anesthetic is being recalled voluntarily by Teligent Pharma, the FDA announced.
Glass bottles of lidocaine HCl topical solution in 50ml have been recalled due to being classified as a super potent product, after the firms testing the item found an out of specification result at the 18-month stability point. An increased dose could lead to local anesthetic systemic toxicity, which eventually can lead to central nervous system reactions, bradycardia, hypotension. and cardiovascular collapse. That can lead to death, the FDA’s risk statement says.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
